Volitionrx (VNRX) Invested Capital (2019 - 2025)
Volitionrx (VNRX) has disclosed Invested Capital for 9 consecutive years, with -$29.5 million as the latest value for Q3 2025.
- For the quarter ending Q3 2025, Invested Capital fell 65.22% year-over-year to -$29.5 million, compared with a TTM value of -$29.5 million through Sep 2025, down 65.22%, and an annual FY2024 reading of -$21.3 million, down 147.66% over the prior year.
- Invested Capital was -$29.5 million for Q3 2025 at Volitionrx, down from -$26.3 million in the prior quarter.
- Across five years, Invested Capital topped out at $34.4 million in Q1 2021 and bottomed at -$29.5 million in Q3 2025.
- Average Invested Capital over 5 years is -$853444.3, with a median of $493084.0 recorded in 2023.
- The sharpest move saw Invested Capital skyrocketed 189.97% in 2021, then plummeted 3717.5% in 2024.
- Year by year, Invested Capital stood at $17.8 million in 2021, then plummeted by 116.91% to -$3.0 million in 2022, then crashed by 186.17% to -$8.6 million in 2023, then crashed by 147.66% to -$21.3 million in 2024, then crashed by 38.39% to -$29.5 million in 2025.
- Business Quant data shows Invested Capital for VNRX at -$29.5 million in Q3 2025, -$26.3 million in Q2 2025, and -$22.6 million in Q1 2025.